よむ、つかう、まなぶ。
参考資料６ 国民の健康の増進の総合的な推進を図るための基本的な方針（平成24年厚生労働省告示第430号）及び健康日本21（第二次）の推進に関する参考資料 (67 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_24115.html |
| 出典情報 | 健康日本21（第二次）推進専門委員会（第17回 2／25）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.14. Hamer M, Chida Y.
Walking and primary prevention: a meta-analysis of prospective cohort studies. Br J Sports
Med 2008; 42: 238-43
14) Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of prospective cohort studies.
Br J Sports Med 2008; 42: 238-43.15.
15) Ueshima H, Mikawa K, Baba S, et al. Effect of reduced alcohol consumption on blood pressure
in untreated hypertensive men. Hypertension 1993; 21: 248-52.
16) Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different
blood-pressure-lowering regimens on major cardiovascular events: results of
prospectively-designed overviews of randomised trials. Lancet 2003; 362(9395): 1527-35.
17) Rumana N, Kita Y, Turin TC, et al. Trend of increase in the incidence of acute myocardial
infarction in a Japanese population: Takashima AMI Registry, 1990-2001. Am J Epidemiol 2008;
167: 1358-64.
18) Shepherd J, Blauw GJ, Murphy MB, et al. PROspective Study of Pravastatin in the Elderly at
Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised
controlled trial. Lancet 2002; 360(9346): 1623-30.
19) Okamura T, Tanaka H, Miyamatsu N, et al. The relationship between serum total cholesterol
and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort.
Atherosclerosis 2007; 190: 216-223.
20) Jacobs D, Blackburn H, Higgins M, et al. Report of the Conference on Low Blood Cholesterol:
Mortality Associations. Circulation 1992; 86: 1046-60.
21) Smith GD, Shipley MJ, Marmot MG, et al. Plasma cholesterol concentration and mortality. The
Whitehall Study. JAMA 1992; 267: 70-6.
22) Imamura T, Doi Y, Arima H, et al. LDL cholesterol and the development of stroke subtypes and coronary
heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: 382-8.
23) Murakami Y, Miura K, Okamura T, et al. Population attributable numbers and fractions of deaths
due to smoking: a pooled analysis of 180,000 Japanese. Prev Med 2011; 52(1):60-5.
24) 平成 23 年度厚生労働科学研究「大規模コホート共同研究の発展による危険因子管理の優先順位の把
握と個人リスク評価に関するエビデンスの構築（H23-循環器等（生習）－一般－005）」報告書
50
Walking and primary prevention: a meta-analysis of prospective cohort studies. Br J Sports
Med 2008; 42: 238-43
14) Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of prospective cohort studies.
Br J Sports Med 2008; 42: 238-43.15.
15) Ueshima H, Mikawa K, Baba S, et al. Effect of reduced alcohol consumption on blood pressure
in untreated hypertensive men. Hypertension 1993; 21: 248-52.
16) Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different
blood-pressure-lowering regimens on major cardiovascular events: results of
prospectively-designed overviews of randomised trials. Lancet 2003; 362(9395): 1527-35.
17) Rumana N, Kita Y, Turin TC, et al. Trend of increase in the incidence of acute myocardial
infarction in a Japanese population: Takashima AMI Registry, 1990-2001. Am J Epidemiol 2008;
167: 1358-64.
18) Shepherd J, Blauw GJ, Murphy MB, et al. PROspective Study of Pravastatin in the Elderly at
Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised
controlled trial. Lancet 2002; 360(9346): 1623-30.
19) Okamura T, Tanaka H, Miyamatsu N, et al. The relationship between serum total cholesterol
and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort.
Atherosclerosis 2007; 190: 216-223.
20) Jacobs D, Blackburn H, Higgins M, et al. Report of the Conference on Low Blood Cholesterol:
Mortality Associations. Circulation 1992; 86: 1046-60.
21) Smith GD, Shipley MJ, Marmot MG, et al. Plasma cholesterol concentration and mortality. The
Whitehall Study. JAMA 1992; 267: 70-6.
22) Imamura T, Doi Y, Arima H, et al. LDL cholesterol and the development of stroke subtypes and coronary
heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: 382-8.
23) Murakami Y, Miura K, Okamura T, et al. Population attributable numbers and fractions of deaths
due to smoking: a pooled analysis of 180,000 Japanese. Prev Med 2011; 52(1):60-5.
24) 平成 23 年度厚生労働科学研究「大規模コホート共同研究の発展による危険因子管理の優先順位の把
握と個人リスク評価に関するエビデンスの構築（H23-循環器等（生習）－一般－005）」報告書
50